Journal of Current Glaucoma Practice

Register      Login

VOLUME 7 , ISSUE 1 ( January-April, 2013 ) > List of Articles

Original Article

Preimplantation Flow Testing of Ahmed Glaucoma Valve and the Early Postoperative Clinical Outcome

Emma Jones, Pouya Alaghband, Jason Cheng, Laura Beltran-Agullo, Kin Sheng Lim

Keywords : Glaucoma, Aqueous shunt, Methods, Adverse effects, Ahmed implant

Citation Information : Jones E, Alaghband P, Cheng J, Beltran-Agullo L, Lim KS. Preimplantation Flow Testing of Ahmed Glaucoma Valve and the Early Postoperative Clinical Outcome. J Curr Glaucoma Pract 2013; 7 (1):1-5.

DOI: 10.5005/jp-journals-10008-1128

License: CC BY-NC 4.0

Published Online: 01-04-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Purpose: The Ahmed glaucoma valve (AGV) implant is designed to prevent early postoperative hypotony. There is evidence of variation in hypotony rates in clinical trials which may be due to surgical technique variation, entry site leakage or valve defects from ‘over priming’. We describe a simple preimplantation gravity driven test to assess valve function after priming that may reduce hypotony rates. Materials and methods: Retrospective case note review. An in vivo flow test of AGVs, based on the gravity driven test was introduced prior to implantation. The onset and offset of flow through the valve was measured by altering the height of a bottle of balanced saline solution. We rejected the AGV, if there was fluid still flowing at 10 cm (7 mm Hg) or if there was no flow at 17 cm of water (12 mm Hg). The AGV implantation surgery was without mitomycin C, with a 25G needle entry tract, a corneal or scleral patch graft tube cover and without intracameral viscoelastic. Results: Twenty Ahmed valves were implanted in 16 patients between July 2008 and October 2009. Test failure resulted in four AGV being rejected. The mean preoperative pressure was 29 mm Hg (range, 10-57 mm Hg) and the intraocular pressure (IOP) at 7 days postoperatively was 15 mm Hg (range, 3-52 mm Hg). Hypotony, defined as an IOP of less than 5 mm Hg on two consecutive assessments, was present in two eyes (10%). Conclusion: In vivo flow testing is an important safety check for the AGV. There are also other mechanisms after implantation that can cause an unexpected high or low IOP.


PDF Share
  1. Ayyala RS, Michelini-Norris B, Flores A, Haller E, Margo CE. Comparison of different biomaterials for glaucoma drainage devices: Part 2. Arch Ophthalmol 2000 Aug;118(8):1081-1084.
  2. Moss EB, Trope GE. Assessment of closing pressure in silicone Ahmed FP7 glaucoma valves. J Glaucoma 2008 Sep;17(6): 489-493.
  3. Sarkisian SR Jr. Tube shunt complications and their prevention. Curr Opin Ophthalmol 2009 Mar;20(2):126-130.
  4. Freedman J, Trope GE. How to insert a glaucoma implant. In: Trope GE, editor. Glaucoma Surgery. Boca Raton: Taylor and Francis; 2005. p. 63-74.
  5. Porter JM, Krawczyk CH, Carey RF. In vitro flow testing of glaucoma drainage devices. Ophthalmology 1997 Oct;104(10): 1701-1707.
  6. Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology 2011 Mar;118(3):443-452.
  7. Tranos P, Bhar G, Little B. Postoperative intraocular pressure spikes: The need to treat. Eye (Lond) 2004 Jul;18(7):673-679.
  8. Ishida K, Netland PA, Costa VP, Shiroma L, Khan B, Ahmed II. Comparison of polypropylene and silicone Ahmed Glaucoma Valves. Ophthalmology 2006 Aug;113(8):1320-1326.
  9. Hinkle DM, Zurakowski D, Ayyala RS. A comparison of the polypropylene plate Ahmed glaucoma valve to the silicone plate Ahmed glaucoma flexible valve. Eur J Ophthalmol 2007 Sep- Oct;17(5):696-701.
  10. Choritz L, Koynov K, Renieri G, Barton K, Pfeiffer N, Thieme H. Surface topographies of glaucoma drainage devices and their influence on human tenon fibroblast adhesion. Invest Ophthalmol Vis Sci 2010 Aug;51(8):4047-4053.
  11. Jacob J, Stalmans I, Zeyen T. Ahmed and Baerveldt glaucoma drainage implants: long-term results and factors influencing outcome. Bull Soc Belge Ophtalmol 2009;(313):19-29.
  12. Lim KS, Wells AP, Khaw PT. Needle perforations of Molteno tubes. J Glaucoma 2002 Oct;11(5):434-438.
  13. Brooks SE, Dacey MP, Lee MB, Baerveldt G. Modification of the glaucoma drainage implant to prevent early postoperative hypertension and hypotony: a laboratory study. Ophthalmic Surg 1994 May;25(5):311-316.
  14. Sherwood MB, Smith MF. Prevention of early hypotony associated with Molteno implants by a new occluding stent technique. Ophthalmology 1993 Jan;100(1):85-90.
  15. Christakis PG, Kalenak JW, Zurakowski D, Tsai JC, Kammer JA, Harasymowycz PJ, Ahmed II. The Ahmed Versus Baerveldt study: one-year treatment outcomes. Ophthalmology 2011 Nov;118(11):2180-2189.
  16. Huang MC, Netland PA, Coleman AL, Siegner SW, Moster MR, Hill RA. Intermediate-term clinical experience with the Ahmed Glaucoma Valve Implant. Am J Ophthalmol 1999 Jan;127(1):27-33.
  17. Coleman AL, Hill R, Wilson MR, Choplin N, Kotas-Neumann R, Tam M, Bacharach J, Panek WC. Initial clinical experience with the Ahmed Glaucoma Valve Implant. Am J Ophthalmol 1995 Jul;120(1):23-31.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.